DOCSLIB.ORG

Lymphoscintigraphy and the Use of Intraoperative Gamma Probe For

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Lymphoscintigraphy and the Use of Intraoperative Gamma Probe For Society of Nuclear Medicine Procedure Guideline for Lymphoscintigraphy and the Use of Intraoperative Gamma Probe for Sentinel Lymph Node Localization in Melanoma of Intermediate Thickness version 1.0, approved June 15, 2002 Authors: Naomi Alazraki, MD (Emory University School of Medicine, Veterans Affairs Medical Center, Atlanta, GA); Ed- win C. Glass, MD (Wadsworth Veterans Affairs Medical Center, Los Angeles, CA); Frank Castronovo, PhD (Harvard Medical School, Brigham and Women’s Hospital, Boston, MA); Renato A. Valdés Olmos, MD (Netherlands Cancer Insti- tute, Amsterdam, The Netherlands); and Donald Podoloff, MD (MD Anderson Cancer Center, Houston, TX). I. Purpose to make a smaller incision directly over the node, based on the image and probe counts. The purpose of this guideline is to assist nuclear Lymphoscintigraphy images readily demon- medicine practitioners in recommending, perform- strate the unpredictability of lymphatic drainage ing, interpreting, and reporting the results of (1) patterns. Sentinel lymph node biopsy, after iden- lymphoscintigraphy for identifying sentinel lymph tification by lymphoscintigraphy and excision us- nodes for excisional biopsy in patients with ing the intraoperative gamma probe and/or blue melanoma and (2) the use of the intraoperative dye technique, is frequently performed in pa- gamma probe in the operating room. tients without either clinically apparent metas- tases or early intermediate-stage melanoma II. Background Information and Definitions (Clark level <4; Breslow thickness 0.76–4 mm) be- A. This guideline is written specifically for lym- cause of its significant diagnostic and prognostic phoscintigraphy in patients with primary in f o r m a t i o n . melanomas that originate in the skin. Staging of B. Definitions these tumors is based on tumor thickness (Bres- 1. Lymphoscintigraphy: Imaging pathways of low measurement) and level of skin invasion lymphatic flow and lymph nodes after injec- (Clark’s level), both of which are determined by tion of a radiopharmaceutical that is absorbed the pathologist from a biopsy sample. Ample by the lymphatics. data correlate patient survival with Breslow and 2. Sentinel lymph node: The first lymph node in Clark measurements. a lymph node bed to receive lymphatic In the past, elective lymph node dissection drainage from a tumor. Often drainage to (ELND) of the lymphatic bed believed most more than 1 lymph node group and sentinel likely to drain the primary tumor site (based on node is identified. Sappey’s classic anatomic description of cuta- 3. Blue dye technique: Intraoperative injection neous lymphatic flow) was used as part of the (usually peritumoral) of isosulfan blue dye for staging procedure for melanoma. ELND has the purpose of staining lymphatic vessels and been a controversial staging procedure for pa- sentinel lymph nodes so that they can be iden- tients with intermediate (I and II) stage tified visually during surgery for excisional melanoma, because approximately 80% have tu- biopsy. mor-negative lymph nodes and therefore do not 4. Gamma-detecting intraoperative probe: need ELND, a procedure associated with signifi- Small, hand-held radiation-detecting device cant morbidity and cost. The sentinel lymph that uses auditory signals and meter read-outs node excisional biopsy procedure, in contrast, is of counts detected. The intraoperative gamma simpler and not associated with significant mor- probe can be used effectively by the surgeon bidity, provides accurate information about lym- and nuclear medicine physician as a guide to phatic drainage patterns, and allows the surgeon find the radiolabeled sentinel lymph node(s). 136 · LYMPHOSCINTIGRAPHY III. Common Indications 1. Radiotracer injections a. Approximately 0.1mL containing at least A. Sentinel node localization and excision using ra- 3.7 MBq (100 µCi) Tc-99m sulfur colloid, dionuclide methods are performed in the care of filtered (0.22µ millipore filter), is adminis- patients with: tered as 4–8 peritumoral intradermal injec- 1. Intermediate stage primary melanoma (Bres- tions (fewer than 4 may be performed if ap- low 0.76 mm–4.0 mm). propriate) within 1 cm from the melanoma 2. No clinical evidence of nodal involvement. or the excisional biopsy site at which the 3. No clinical evidence of distant tumor spread. melanoma was located. B. Exclusions may include patients with: b. Injections should surround the lesion or 1. Extensive previous surgery in the region of biopsy site to best sample lymphatic the primary tumor site or targeted lymph drainage in all directions. An exception node bed. may be in primary cutaneous melanoma in 2. Patients with known metastases. the head or neck, in which lymphatic drainage is often caudad. Injections infe- IV. Procedure rior to those lesions may be omitted to avoid masking a sentinel node in close A. Patient Preparation proximity to the primary lesion. There are no dietary or medication restrictions c. The injection should be performed by an au- for the procedure. Patients should follow preop- thorized user physician or his/her designee. erative restrictions if the procedure is performed on the same day as scheduled surgery. d. The high pressure of the intradermal bleb B. Information Pertinent to Performing the Proce- can result in leakage of some of the ra- dure dioactivity on needle removal. Care should The patient usually has had a previous biopsy be taken to avoid radioactive contamina- that showed cutaneous malignancy and the tion, which can be confused with lymph pathological classification of the tumor (Breslow, node “uptake.” thickness of the tumor, and/or Clark, skin-layer e. Gentle finger massage should be consid- penetration of the tumor, which are prognostic). ered at each injection site to promote up- Recent extensive surgical excision of the primary take of the tracer into lymphatic channels lesion can be the cause of a rare unsuccessful and lymphatic flow. study because of surgical disruption of lym- f. The injection site should be covered with a phatic vessel integrity. bandaid or cotton ball to prevent leakage C. Precautions of tracer through the needle puncture site. If surgery is to be performed using the intraop- 2. Dosimetry erative gamma probe to assist in finding the sen- In the dosimetry tables included here, the lo- tinel node, the tracer must be injected approxi- cal radiation dose has been ignored and the mately 0.5–3 h before surgery. If surgery is effective dose has been calculated assuming further delayed (by 6 or more h), another image that 20% of the administered activity has been before surgery is advisable to define further mi- absorbed systemically (Kaplan, 1985). The gration of tracer to additional nodes, if any. reasons for ignoring the local radiation dose D. Radiopharmaceuticals are that: No radiopharmaceuticals have been specifically a. Deterministic effects (e.g., local skin necro- approved by the U.S. Food and Drug Adminis- sis) are not a concern for Tc-99m–labeled tration for lymphoscintigraphy in the United radiopharmaceuticals. States. Tc-99m sulfur colloid is used in the b. The estimated local radiation dose varies United States in a filtered (usually 0.22-mm fil- greatly, depending on the assumptions tration) or unfiltered form. Smaller particles are used (Castronovo 1994; ICRP, 60). generally recommended as more frequent visu- c. The local radiation dose contributes little to alization of lymphatic channels is achieved with the effective dose. A 50-rem dose averaged the filtered formulation. over 10 cm2 skin is comparable with an ef- There is worldwide variation in radiopharma- fective dose of 1.7 mrems (Baum, 2001). ceuticals used for lymphoscintigraphy. Tc-99m d. Melanoma is very uncommon in children antimony trisulfide colloid (particle size, 0.015–0.3 but lymphoscintigraphy is occasionally µm) and Tc-99m nanocolloid (particle size, performed in children to determine the 0.05–0.8 µm) are used in Australia and Europe. cause of extremity swelling. SOCIETY OF NUCLEAR MEDICINE PROCEDURE GUIDELINES MANUAL JUNE 2002 · 137 Radiation Dosimetry for Adults Radiopharmaceutical Administered Activity Organ Receiving the Effective Dose2 La r g e s t Radiation Dose1 mSv/MBq MB q mGy/MBq (rem/mCi) (m C i ) (r a d / m C i ) Tc-99m small 15 – 35 0.015 0.0019 or large colloids1 Intradermal Spleen (0.5-1.0) (0.057) (0.0071) 1 ICRP 53, pp. 180 and 182. 2 ICRP 80. Note: values in this table are only 20% of the values found in ICRP 80 because of the assumption that only 20% of the administered activity is absorbed systemically. E. Image Acquisition node(s) in frontal and lateral views, and/or in 1. Acquisition parameters the patient’s position as it would be on the op- Sequential or continuous imaging begins im- erating room table. Skin marking can be per- mediately after completion of injections and formed using the probe in nuclear medicine, if continues for 30–60 minutes. Continuous available, or using a radioactive marker imaging may include dynamic imaging at 30 source. For trunk lesions, images must in- seconds per frame for 2–30 minutes and/or clude both axillary and both inguinal regions. sequential static images every 5 minutes for Some unusual locations for sentinel nodes in- up to 1 hour or until the sentinel lymph node clude periscapular, costal, and umbilical re- is identified. For trunk lesions, images of both gions. The lateral view is essential, especially axillary and inguinal regions should be ob- for distinguishing periscapular from axillary tained. Lateral or oblique views are often nodes. For head and neck lesions, images helpful to uncover multiple nodes that overlie should include the entire head and neck in an- one another on a single projection. The pa- terior, posterior and/or oblique projections tient’s body contour may be defined on the (whichever places the primary tumor and image in relation to the injection site, lymph sentinel node(s) closest to the camera face), drainage, and sentinel node(s) by transmis- and the lateral view.
Load more

Recommended publications
  • Radioactive Seed Localization of Breast Lesions: an Adequate Localization Method Without Seed Migration
    ORIGINAL ARTICLE Radioactive Seed Localization of Breast Lesions: An Adequate Localization Method without Seed Migration Tanja Alderliesten, PhD,* Claudette E. Loo, MD,* Kenneth E. Pengel, MSc,* Emiel J. Th. Rutgers, MD, PhD, Kenneth G. A. Gilhuijs, PhD,* and Marie-Jeanne T. F. D. Vrancken Peeters, MD, PhD *Department of Radiology; and Department of Surgery, The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital (NKI-AVL), Amsterdam, The Netherlands n Abstract: Preoperative localization is important to optimize the surgical treatment of breast lesions, especially in nonpal- pable lesions. Radioactive seed localization (RSL) using iodine-125 is a relatively new approach. To provide accurate guid- ance to surgery, it is important that the seeds do not migrate after placement. The aim of this study was to assess short-term and long-term seed migration after RSL of breast lesions. In 45 patients, 48 RSL procedures were performed under ultrasound or stereotactic guidance. In the first 12 patients, the lesion was localized with two markers: an iodine-125 seed and a refer- ence marker. In 33 patients, 36 RSL procedures were performed using a single iodine-125 seed. All patients received control mammograms after seed placement and prior to surgery. In the patients with two markers, migration was defined as the differ- ence in the largest distance between the markers observed in the mammograms. For single-marked lesions, migration was assessed by comparing distances between anatomical landmarks in the mammograms. RSL was successful in all patients. Seeds were in-situ for 59.5 days on average (3–136 days). The detection rate during surgery was 100%.
    [Show full text]
  • Nuclear Technology Reivew for 2002
    GC GC(46)/INF/5 16 July 2002 International Atomic Energy Agency GENERAL Distr. GENERAL CONFERENCE Original: ENGLISH Forty-sixth regular session Item 15 of the provisional agenda (GC(46)/1) NUCLEAR TECHNOLOGY REVIEW 2002 1. In response to requests by Member States, the Secretariat produces a comprehensive Nuclear Technology Review every two years, with a shorter supplement in the intervening years. The present report is the second comprehensive compilation giving a global perspective on nuclear technologies for both power and non-power applications. 2. The NTR-2002 contains an Executive Summary and then reviews the following areas: Fundamentals of Nuclear Development; Nuclear Power, Fuel Cycle and Waste Management; Applications for Food, Water and Health; and Applications for Environment and Sustainable Industrial Processes. 3. The document has been modified to take account, to the extent possible, of specific comments by the Board and other comments received from Member States. For reasons of economy, this document has been printed in a limited number. Delegates are kindly requested to bring their copies of documents to meetings. GC(46)/INF/5 Page 2 NUCLEAR TECHNOLOGY REVIEW 2002 Table of Contents EXECUTIVE SUMMARY 4 PART I. FUNDAMENTALS OF NUCLEAR DEVELOPMENT 7 I-1. NUCLEAR, ATOMIC AND MOLECULAR DATA 7 I-2. RESEARCH REACTORS, ACCELERATORS AND RADIOISOTOPES 9 I-2.1. Research Reactors 9 I-2.2. Accelerators 11 I-2.3. Radioisotopes 13 I-3. NUCLEAR INSTRUMENTATION 14 I-4. NUCLEAR FUSION 15 PART II. NUCLEAR POWER, FUEL CYCLE AND WASTE MANAGEMENT 17 II-1. THE GLOBAL NUCLEAR POWER PICTURE 17 II-1.1.
    [Show full text]
  • Intraoperative Gamma Probe Detection of Bone Invasive
    Intraoperative and Postoperative Gamma Detection of Somatostatin Receptors in Bone Invasive “En Plaque” Meningiomas Emmanuel GAY, MD; Jean Philippe VUILLEZ, MD, PhD; Olivier PALOMBI, MD; Pierre Yves BRARD, MD; Pierre BESSOU, MD and Jean Guy PASSAGIA, MD. Department of Neurosurgery (EG, OP, JGP), Department of Nuclear Medecine (JPhV, PYB) and Departement of Neuroradiology (PB), University Hospital Grenoble, France. This is a non-final version of an article published in final form in Neurosurgery: July 2005 - Volume 57 - Issue 1 - pp 107-113 E. GAY Corresponding author: Emmanuel GAY, MD Department of Neurosurgery (Pr A.L. Benabid) CHU Grenoble BP217 38043 Grenoble Cedex 09 FRANCE Tel: 33 476 76 54 71 Fax: 33 476 76 58 13 Email: [email protected] 2 E. GAY Intraoperative and Postoperative Gamma Detection… Abstract: Objective: Scintigraphy with radiolabeled somatostatin analogue ([111In-DTPA] octreotide), detects the somatostatin receptors that are found in vitro in all meningiomas. Previous studies have proved the benefit of radioimmunoguided surgery with a handheld gamma probe, for the assessment and the removal of neuroendocrine tumors. We conducted a study to determine whether intraoperative radiodetection of somatostastin receptors is feasible and could increase the probability of complete meningioma resection, especially for bone invasive “en plaque” meningiomas that are difficult to control surgically. Methods: Eighteen patients with “en plaque” sphenoid wing and skull convexity meningiomas were studied for pre and post-operative somatostatin receptor scintigraphy. In 10 of them, intraoperative radiodetection using a handheld gamma probe was performed 24 hours after the intravenous administration of [111In-DTPA] octreotide. This procedure was combined with a computer-aided navigation system.
    [Show full text]
  • (EANM) Acceptance Testing for Nuclear Medicine Instrumentation
    Eur J Nucl Med Mol Imaging (2010) 37:672–681 DOI 10.1007/s00259-009-1348-x GUIDELINES Acceptance testing for nuclear medicine instrumentation Ellinor Busemann Sokole & Anna Płachcínska & Alan Britten & on behalf of the EANM Physics Committee Published online: 5 February 2010 # EANM 2010 Keywords Quality control . Quality assurance . requirement that acceptance testing be performed should Acceptance testing . Nuclear medicine instrumentation . be included in the purchase agreement of an instrument. Gamma camera . SPECT. PET. CT. Radionuclide calibrator. This agreement should specify responsibilities regarding Thyropid uptake probe . Nonimaging intraoperative probe . who does acceptance testing, the procedure to be followed Gamma counting system . Radiation monitors . when unsatisfactory results are obtained, and who supplies Preclinical PET the required phantoms and software. A specific time slot must be allocated for performing acceptance tests. Introduction Acceptance and reference tests These recommendations cover acceptance and reference tests that should be performed for acceptance testing of Acceptance tests are performed to verify that the instrument instrumentation used within a nuclear medicine department. performs according to its specifications. Each instrument is These tests must be performed after installation and before supplied with a set of basic specifications. These have been the instrument is put into clinical use, and before final produced by the manufacturer according to standard test payment for the device. These recommendations
    [Show full text]
  • Paper RADIOACTIVE SEED LOCALIZATION with I for NONPALPABLE LESIONS PRIOR to BREAST LUMPECTOMY AND/OR EXCISIONAL BIOPSY
    Paper RADIOACTIVE SEED LOCALIZATION WITH 125I FOR NONPALPABLE LESIONS PRIOR TO BREAST LUMPECTOMY AND/OR EXCISIONAL BIOPSY: METHODOLOGY, SAFETY, AND EXPERIENCE OF INITIAL YEAR Lawrence T. Dauer,*† Cynthia Thornton,† Daniel Miodownik,* Daniel Boylan,* Brian Holahan,* Valencia King,‡ Edi Brogi,§ Monica Morrow,** Elizabeth A. Morris,† and Jean St. Germain* INTRODUCTION AbstractVThe use of radioactive seed localization (RSL) as an alternative to wire localizations (WL) for nonpalpable breast IMPROVEMENTS IN imaging techniques and increasing rates lesions is rapidly gaining acceptance because of its advantages of screening mammograms have resulted in the increased for both the patient and the surgical staff. This paper exam- ines the initial experience with over 1,200 patients seen at a detection of nonpalpable breast lesions that require locali- comprehensive cancer center. Radiation safety procedures for zation prior to surgery to allow excision for complete his- radiology, surgery, and pathology were implemented, and ra- tological evaluation or as part of breast-conserving therapy dioactive material inventory control was maintained using an (Harris et al. 1981; Homer 1983; Cady et al. 1996; Montrey intranet-based program. Surgical probes allowed for discrimina- tion between 125I seed photon energies from 99mTc administered for et al. 1996; Bartelink et al. 2001; Skinner et al. 2001; Hooley sentinel node testing. A total of 1,127 patients (median age et al. 2012; Nederend et al. 2012). Breast image-guided of 57.2 y) underwent RSL procedures with 1,223 seeds im- localization is performed on nonpalpable lesions after Y planted. Implanted seed depth ranged from 10.3 107.8 mm. marker clips are left in the breast following image-guided The median length of time from RSL implant to surgical excision was 2 d.
    [Show full text]
  • Radioactive Materials Transportation and Incident Response
    RADIOACTIVE MATERIALS TRANSPORTATION AND INCIDENT RESPONSE U.S. Department of Energy Transportation Emergency Preparedness Program Q&A About Incident Response 04/12 QA Phone Number Radio Frequency Law Enforcement ____________________________________ RADIOACTIVE Fire ___________________________________________ MATERIALS Medical ____________________________________________ TRANSPORTATION AND INCIDENT RESPONSE State Radiological Assistance ___________________________ Local Government Official ______________________________ Local Emergency Management Agency ___________________ State Emergency Management Agency ___________________ HAZMAT Team ______________________________________ Water Pollution Control ________________________________ CHEMTEL (Toll-free US & Canada) 1-800-255-3924 _________ CHEMTREC (Toll-free US & Canada) 1-800-424-9300 _______ CHEMTREC (Outside US) 1-703-527-3887 ________________ National Response Center (Toll-free US & Canada) 1-800-424-8802 ____________ In Washington, D.C. 1-202-267-2675 _____________________ Military Shipments (DoD) Call Collect 1-703-697-0218 _______ Other: ______________________________________________ Other: ______________________________________________ QQ&A About Incident Response NOTES TABLE OF CONTENTS What is radiation?.................................................................................... 2 ______________________________________________ What is radiation exposure? .................................................................... 3 ______________________________________________
    [Show full text]
  • Spectral Gamma Probe Analyses the Energy Spectrum of Gamma Radiation from Naturally Occurring Or Man-Made Isotopes in the Formation Surrounding a Borehole
    PROBES SPECTRAL GAMMA The Spectral Gamma probe analyses the energy spectrum of gamma radiation from naturally occurring or man-made isotopes in the formation surrounding a borehole. The probe corrects for temperature drift in real-time by matching the acquired spectrum to the base spectra of the main Probe Head natural emitters (potassium, uranium and thorium) determined during the tool master calibration. Available outputs are full-spectrum (static mode only) and continuous log measurements of elemental concentrations. Borehole corrections are available for casing thickness, borehole diameter, formation density and mud/fluid radioactivity for both centralized and side-walled tool positions. Principle of Measurement: Gamma photons produced by the decay of naturally occurring potassium, uranium, thorium and/or unstable man-made isotopes in the formation are detected by a large-volume gamma scintillation counter and converted to electrical pulses. The amplitude of the pulses depends on the photon energy. An analyzer within the probe separates the pulses into channels according to their amplitudes. Count-rates from groups of channels are converted in real-time by the surface software to concentrations of the originating elements using predetermined algorithms. SPECIFICATION: Features Large-volume scintillation detector for high sensitivity Temperature compensation ensures freedom from drift Measurements Uranium (ppm) Thorium (ppm) Potassium (%) Gross Gamma Full spectrum display 100keV – 3MeV Applications Minerals / Water / Engineering 1.72m Shale/Clay typing (67.7”) Correlation in complex situations Mineral detection Radioactive waste pollution measurement Lithology determination Operating Conditions Borehole type: open/cased, water/air filled Recommended Logging Speed: 1m/min Specifications Diameter: 48mm or 60mm Length: 1.72m (for both types) Weight: 7kg (60mm version) Temperature: 0-70°C Max.
    [Show full text]
  • Wprobe: Exploring New Frontiers in Radioguided Cancer Surgery
    Wireless gamma probe for radioguided Sentinel lymph Node (SLN) Localization WProbe: Exploring new frontiers in radioguided cancer surgery Precise . Comfortable . Easy Since 2007 ONCOVISION has been fully committed to help you improve your high standards in Minimally Invasive Radio- guided Surgery (MIRS) with an innovative radioguided technological platform that is revolutionizing the surgical management of malignancies such us breast cancer, melanoma, gynecological, urological and colorectal cancers, and parathyroid diseases. Sentinella and WProbe provide you the perfect combination, to be used together or independently, to guide you through even the most complex Sentinel Lymph Node (SLN) localizations in the management of your cancer patients9. What is radioguided surgery and how does it work? The concept of the Sentinel Lymph Node However, the latest breakthrough in radiosurgery (SLN) as the first node to have metastatic is Sentinella, an intraoperative portable involvement if there has been lymphatic spread gammacamera (intraoperative imaging) that brings was proposed by Dr. R. Cabañas in 1977. real time imaging and greater sensitivity to the The first accepted technique to identify the SLN was OR improving the SNL technique and allowing using blue dye (intraoperative visualization); soon, the surgeon to visualize and reach out even the however, the use of radionuclides and intraoperative most hidden and deep hot nodes in cancer gamma probes (intraoperative counting) came procedures. The use of Sentinella is quickly on board as a complementary yet more reliable expanding to additional sophisticated and complex technique3. indications6. The intraoperative gamma probe technology with WProbe, is based on the injection in the tumor site of a radiopharmaceutical agent that emits gamma rays while it drains towards the lymphatic system.
    [Show full text]
  • Real-Time Measurement of Radionuclides in Soil
    1 Welcome – Thanks for joining us. ITRC’s Internet-based Training Program Real-Time Measurement of Radionuclides in Soil Real-Time Measurement of Radionuclides in Soil: Technology and Case Studies This training is co-sponsored by the US EPA Office of Superfund Remediation and Technology Innovation Presentation Overview: U.S. Department of Energy (DOE) and Nuclear Regulatory Commission (NRC) sites and some Superfund and U.S. Department of Defense (DOD) sites are contaminated with radionuclides. Radioactive contamination is also an issue potentially faced by Homeland Security. Characterization of radionuclides is an expensive and time- consuming process. Using real-time technologies to complete initial screening and characterization of radionuclide contamination results in more timely and cost-effective characterizations. Real-time technologies can also direct excavation resulting in more timely and cost-effective cleanups. The result is earlier protection of human health and the environment. This training introduces state regulators, environmental consultants, site owners, and community stakeholders to ITRC's Technology Overview document Real-Time Measurement of Radionuclides in Soil: Technology and Case Studies (RAD-4, 2006), created by ITRC's Radionuclides Team. This training provides information on the basics of real- time measurement systems (detector types and platforms, location control and mapping technologies, surface and subsurface applications and limitations), how the technologies and data are used (characterization, remediation
    [Show full text]
  • NUCLEAR TECHNOLOGY REVIEW 2012 NUCLEAR TECHNOLOGY REVIEW 2012 International Atomic Energy Agency International Atomic Energy
    NUCLEAR TECHNOLOGY REVIEW 2012 NUCLEAR TECHNOLOGY REVIEW 2012 International Atomic Energy Agency www.iaea.orgAtoms for Peace International Atomic Energy Agency Vienna International Centre PO Box 100 1400 Vienna, Austria Telephone:Atoms for(+43-1) Peace 2600-0 @ Fax: (+43-1) 2600-7 Email: [email protected] NUCLEAR TECHNOLOGY REVIEW 2012 The following States are Members of the International Atomic Energy Agency: AFGHANISTAN GHANA NIGERIA ALBANIA GREECE NORWAY ALGERIA GUATEMALA OMAN ANGOLA HAITI PAKISTAN ARGENTINA HOLY SEE PALAU ARMENIA HONDURAS PANAMA AUSTRALIA HUNGARY PAPUA NEW GUINEA AUSTRIA ICELAND PARAGUAY AZERBAIJAN INDIA PERU BAHRAIN INDONESIA PHILIPPINES BANGLADESH IRAN, ISLAMIC REPUBLIC OF POLAND BELARUS IRAQ PORTUGAL BELGIUM IRELAND QATAR BELIZE ISRAEL REPUBLIC OF MOLDOVA BENIN ITALY ROMANIA BOLIVIA JAMAICA RUSSIAN FEDERATION BOSNIA AND HERZEGOVINA JAPAN SAUDI ARABIA BOTSWANA JORDAN SENEGAL BRAZIL KAZAKHSTAN SERBIA BULGARIA KENYA SEYCHELLES BURKINA FASO KOREA, REPUBLIC OF SIERRA LEONE BURUNDI KUWAIT SINGAPORE CAMBODIA KYRGYZSTAN SLOVAKIA CAMEROON LAO PEOPLE’S DEMOCRATIC SLOVENIA CANADA REPUBLIC SOUTH AFRICA CENTRAL AFRICAN LATVIA SPAIN REPUBLIC LEBANON SRI LANKA CHAD LESOTHO SUDAN CHILE LIBERIA CHINA LIBYA SWEDEN COLOMBIA LIECHTENSTEIN SWITZERLAND CONGO LITHUANIA SYRIAN ARAB REPUBLIC COSTA RICA LUXEMBOURG TAJIKISTAN CÔTE D’IVOIRE MADAGASCAR THAILAND CROATIA MALAWI THE FORMER YUGOSLAV CUBA MALAYSIA REPUBLIC OF MACEDONIA CYPRUS MALI TUNISIA CZECH REPUBLIC MALTA TURKEY DEMOCRATIC REPUBLIC MARSHALL ISLANDS UGANDA OF THE CONGO
    [Show full text]
  • SNMMI Nuclear Medicine Technology Competency Based Curriculum
    Nuclear Medicine Technology Competency- Based Curriculum Guide 5th Edition Introduction Competency-based education in nuclear medicine technology focuses on those elements necessary to become an entry-level nuclear medicine technologist. Emphasizing competencies communicates entry-level knowledge, skills, attitudes, and behaviors that the nuclear medicine technology curriculum must address and that employers can expect of graduates. Competency- based education allows more flexibility in pedagogical approaches to achieve these essential competencies. The competencies are divided into eight sections: 1. Radiation Safety 2. Instrumentation, Quality Control and Quality Assurance 3. Radiopharmacy and Pharmacology 4. Diagnostic and Therapeutic Procedures 5. Patient Care 6. Professionalism and Interpersonal Communication Skills 7. Organization Systems-Based Practice 8. Research Methodology Each section lists the competencies that must be achieved by the entry level nuclear medicine technologist. The rigor of the nuclear medicine technologist entry-level competencies is such that a significant body of knowledge, skills, and experience is necessary to achieve them. This level of rigor is consistent with the Society of Nuclear Medicine and Molecular Imaging—Technologist Section’s (SNMMI-TS) recommendation that the entry-level degree for a nuclear medicine technologist should be at the baccalaureate level. The content listed under the competencies is intended to be used as a guide for what may be included in a program’s curriculum to achieve minimal competency in each area. The specific content listed should be used at the program’s discretion to meet individual curricular and accreditation needs. The content in its entirety is not considered mandatory, and other pedagogies may equally meet each program’s needs.
    [Show full text]
  • Simultaneous Acquisition of Ultrasound and Gamma Signals with a Single-Channel Readout
    sensors Communication Simultaneous Acquisition of Ultrasound and Gamma Signals with a Single-Channel Readout Muhammad Nasir Ullah 1,2,3, Yuseung Park 2,4 , Gyeong Beom Kim 2,4, Chanho Kim 2 , Chansun Park 1,2 , Hojong Choi 3,* and Jung-Yeol Yeom 1,2,4,5,* 1 Global Health-Tech Research Center, Korea University, 145 Anam-ro, Seoul 02841, Korea; [email protected] (M.N.U.); [email protected] (C.P.) 2 Department of Bioengineering, Korea University, 145 Anam-ro, Seoul 02841, Korea; [email protected] (Y.P.); [email protected] (G.B.K.); [email protected] (C.K.) 3 Department of Medical IT Convergence Engineering, Kumoh National Institute of Technology, 350-27 Gumi-daero, Gumi 39253, Korea 4 Interdisciplinary Program in Precision Public Health, Korea University, 145 Anam-ro, Seoul 02841, Korea 5 School of Biomedical Engineering, Korea University, 145 Anam-ro, Seoul 02841, Korea * Correspondence: [email protected] (H.C.); [email protected] (J.-Y.Y.); Tel.: +82-54-478-7782 (H.C.); +82-2-3290-5662 (J.-Y.Y.) Abstract: We propose an integrated front-end data acquisition circuit for a hybrid ultrasound (US)- gamma probe. The proposed circuit consists of three main parts: (1) a preamplifier for the gamma probe, (2) a preprocessing analog circuit for the US, and (3) a digitally controlled analog switch. By exploiting the long idle time of the US system, an analog switch can be used to acquire data of both systems using a single output channel simultaneously. On the nuclear medicine (NM) gamma probe side, energy resolutions of 18.4% and 17.5% were acquired with the standalone system and with the proposed switching circuit, respectively, when irradiated with a Co-57 radiation source.
    [Show full text]